In a regulatory filing, Ajanta Pharma stated that it is fully cooperating with officials and providing the clarifications and details sought by them, and will continue to share any further information as required. Shares of Ajanta Pharma Ltd ended at ₹2,681.50, down by ₹25.35, or 0.94%, on the BSE.
